.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Chubb
UBS
Cantor Fitzgerald
Harvard Business School
US Army
Merck
Colorcon
Accenture

Generated: January 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Switzerland Patent: 97/331

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
NovartisTRILEPTALoxcarbazepineSUSPENSION;ORAL021285-001May 25, 2001ABRXYesYes➤ Subscribe➤ SubscribeY
NovartisTRILEPTALoxcarbazepineTABLET;ORAL021014-001Jan 14, 2000ABRXYesNo➤ Subscribe➤ SubscribeY
NovartisTRILEPTALoxcarbazepineTABLET;ORAL021014-002Jan 14, 2000ABRXYesNo➤ Subscribe➤ SubscribeY
NovartisTRILEPTALoxcarbazepineTABLET;ORAL021014-003Jan 14, 2000ABRXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist